Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 495

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Identification and use of biomarkers in treatment strategies for triple‐negative breast cancer subtypes

Open access
Lehmann, Brian D, Pietenpol, Jennifer A·2014·The Journal of Pathology

Abstract

Triple‐negative breast cancer (TNBC) is a heterogeneous disease with distinct molecular subtypes that respond differentially to chemotherapy and targeted agents. The absence of high‐frequency molecular alterations and a limited number of known biomarkers have limited the development of therapeutic strategies for the disease. Herein, we summarize the results of the first round of targeted therapy approaches in TNBC and discuss new preclinical strategies. Common themes emerge from the proposed strategies, such as the use of biomarkers to identify tumours with genomic instability, targeting adapted molecular states resulting from tumour suppressor loss, and targeting altered metabolic pathways. Copyright © 2013 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/path.4280

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 495

Metadata

Authors
Lehmann, B. D., & Pietenpol, J. A.
Venue
The Journal of Pathology
Publisher
Wiley
Published
2013-12-10
Volume
232
Issue
2
Pages
142-150
ISSN
  • 0022-3417 (ISSN-L)
  • 1096-9896
OpenAlex
W2139517025
Cited by
495
References
6
FWCI
11.69
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification and use of biomarkers in treatment strategies for triple‐negative breast cancer subtypes. https://app.cochat.ai/papers/10.1002/path.4280
The paper
Lehmann, B. D., & Pietenpol, J. A. (2014). Identification and use of biomarkers in treatment strategies for triple‐negative breast cancer subtypes. The Journal of Pathology. https://doi.org/10.1002/path.4280

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.